Study for certain pregnancy-related tumor conditions
Part of Cancer, Women’s health & pregnancy clinical trials.
This study is for people who have a pregnancy-related tumor called gestational trophoblastic disease. It looks at this condition in patients who were diagnosed by blood test (hCG) changes or tissue testing, to better understand and manage the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of gestational trophoblastic disease (also called trophoblastic disease).
- The diagnosis must be confirmed by tissue testing (a biopsy) showing the disease, or by abnormal hCG blood test levels over time.
- There are no listed extra exclusion criteria in the provided information.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people diagnosed with a hydatidiform mole (a rare pregnancy-related tumor) to understand how it progresses. It follows your health after the mole is removed and checks your hCG levels (a pregnancy hormone) to see if you develop a related condition called post-molar gestational trophoblastic neoplasia.
This study looks at different treatment approaches for hydatidiform mole when a CT scan shows lung nodules and the team cannot rule out spread. It may help guide the safest next steps and follow-up plan.
This study follows people diagnosed with a hydatidiform mole, a rare type of pregnancy growth, to better understand how it progresses and what treatments work best. By participating, you can help improve care for others with this condition.
This study tests whether avelumab (an immune therapy) combined with methotrexate (chemotherapy) can work well as the first treatment for low-risk gestational trophoblastic neoplasia. It aims to improve control of the tumor while keeping side effects acceptable.
This trial is creating a database for women diagnosed with gestational trophoblastic neoplasia (GTN), which includes tumors that can develop after a molar pregnancy or other pregnancy-related conditions. By joining, you help researchers better understand and improve treatment for these rare tumors.
This study looks at tumor tissue and blood samples to find biological “markers” in people with gynecologic cancers. It may help researchers understand disease better and could guide future, more personalized treatments.
Hear when a new Gestational Trophoblastic Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.